IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 158 filers reported holding IMMUNOGEN INC in Q4 2016. The put-call ratio across all filers is 5.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $212,000 | -19.4% | 103,919 | +5.9% | 0.00% | – |
| Q3 2016 | $263,000 | -30.1% | 98,092 | -19.8% | 0.00% | – |
| Q2 2016 | $376,000 | -54.2% | 122,283 | +26.8% | 0.00% | – |
| Q1 2016 | $821,000 | -30.4% | 96,428 | +10.9% | 0.00% | -100.0% |
| Q4 2015 | $1,180,000 | +39.6% | 86,932 | -1.3% | 0.00% | – |
| Q3 2015 | $845,000 | -29.9% | 88,045 | +5.0% | 0.00% | -100.0% |
| Q2 2015 | $1,206,000 | +75.3% | 83,883 | +9.0% | 0.00% | – |
| Q1 2015 | $688,000 | +57.4% | 76,956 | +7.4% | 0.00% | – |
| Q4 2014 | $437,000 | -36.1% | 71,669 | +10.8% | 0.00% | – |
| Q3 2014 | $684,000 | +19.0% | 64,669 | +33.4% | 0.00% | – |
| Q2 2014 | $575,000 | -45.8% | 48,477 | -31.7% | 0.00% | -100.0% |
| Q1 2014 | $1,060,000 | +23.4% | 70,961 | +21.2% | 0.00% | 0.0% |
| Q4 2013 | $859,000 | -7.2% | 58,530 | +7.5% | 0.00% | 0.0% |
| Q3 2013 | $926,000 | +5.9% | 54,422 | +3.3% | 0.00% | 0.0% |
| Q2 2013 | $874,000 | – | 52,663 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |